Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Is multiple sclerosis a proresolution deficiency disorder?
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Tumor-like multiple sclerosis.
[Posture disorders in patients with multiple sclerosis.]
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
DYNACIN (MINOCYCLINE)
Targeting human oligodendrocyte progenitors for myelin repair.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Pediatric multiple sclerosis in Venezuela.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
JC viremia in natalizumab-treated patients with multiple sclerosis.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »